Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; MPN; Blast phase; Leukemic transformation; Acute myeloid leukemia; AML;
مقالات ISI نئوپلاسم میلوپرولیفراتیو (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نئوپلاسم میلوپرولیفراتیو; Automated cell counter parameters; Cell population data; DxH800; Myelodysplastic syndrome; Myeloproliferative neoplasm; Cytopenia;
Keywords: نئوپلاسم میلوپرولیفراتیو; Hypomethylating agents; Monocytosis; Mutations; Myelodysplastic syndrome; Myeloproliferative neoplasm;
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Inflammation; Mutations; PTX-3; hs-CRP;
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Myelofibrosis; Thrombocytopenia; Quality of life; Symptomatology;
Keywords: نئوپلاسم میلوپرولیفراتیو; ASCT; allogeneic stem cell transplantation; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; GVHD; graft versus host disease; IPSS; International Prognostic Scoring System; MPN; myeloproliferative neoplasm; PMF; prima
Keywords: نئوپلاسم میلوپرولیفراتیو; JAK; Janus kinase; STAT; signal transducers and activators of transcription; EPOR; erythropoietin receptor; TPOR; thrombopoietin receptor; G-CSFR; granulocyte colony stimulating factor receptor; γc; common gamma chain; SCID; severe combined immunodeficie
Keywords: نئوپلاسم میلوپرولیفراتیو; Hydroxyurea; JAK2 inhibitor; Myeloproliferative neoplasm; Thalidomide; Treatment;
Keywords: نئوپلاسم میلوپرولیفراتیو; nowotwory mieloproliferacyjne; mutacje JAK2; mutacja JAK2 V617F; czerwienica prawdziwa; nadpÅytkowoÅÄ samoistna; Myeloproliferative neoplasm; JAK2 mutation; JAK2 V617F mutation; Polycythemia vera; Essential thrombocythemia;
Keywords: نئوپلاسم میلوپرولیفراتیو; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplant; BETi; bromodomain and extra terminal domain inhibitor; CR; complete remission; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; FAB; French-American-
Keywords: نئوپلاسم میلوپرولیفراتیو; Cardiac tamponade; Pericardial effusion; Extramedullary hematopoiesis; Myeloproliferative neoplasm; Myelofibrosis;
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation;
Keywords: نئوپلاسم میلوپرولیفراتیو; Blast phase; Decitabine; JAK2; Leukemic transformation; Myeloproliferative neoplasm; Ruxolitinib
Keywords: نئوپلاسم میلوپرولیفراتیو; AMC; absolute monocyte count; AML; acute myeloid leukemia; BM; bone marrow; CMML; chronic myelomonocytic leukemia; CPSS; CMML-Specific Prognostic Scoring System; ESA; erythropoiesis-stimulating agent; GFM; Groupe Français des Myélodysplasies; GVHD; graf
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Myelofibrosis; Vascular complications
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Lymphoproliferative neoplasm; Concurrent; Clinical course
Keywords: نئوپلاسم میلوپرولیفراتیو; Glutamine; Cancer metabolism; Myeloproliferative neoplasm; Glutaminase inhibitor; JAK2 inhibitor
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Myelofibrosis; Wernicke's encephalopathy; Cardiac disorders
Keywords: نئوپلاسم میلوپرولیفراتیو; Myelofibrosis; Myeloproliferative neoplasm; Stem cell transplant;
Keywords: نئوپلاسم میلوپرولیفراتیو; Hematopoietic stem cell transplantation; KIT; Mast cells; Myeloproliferative neoplasm; Tyrosine kinase inhibitor
Keywords: نئوپلاسم میلوپرولیفراتیو; alloSCT; allogeneic stem cell transplant; AML; acute myeloid leukemia; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration; FISH; fluorescence in situ hybridization; G-CSF; granulocyte colony stimulating factor; HSCT; hematopoietic st
Keywords: نئوپلاسم میلوپرولیفراتیو; α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Keywords: نئوپلاسم میلوپرولیفراتیو; Telomerase activity; Myeloproliferative neoplasm; Essential thrombocythemia; Extreme thrombocytosis; Myelodysplastic syndrome;
Keywords: نئوپلاسم میلوپرولیفراتیو; Essential thrombocythemia; MGUS; Myelofibrosis; Myeloproliferative neoplasm; Polycythemia vera;
Keywords: نئوپلاسم میلوپرولیفراتیو; Myelodysplastic syndrome; Myeloproliferative neoplasm; Nonmyeloablative conditioning
Keywords: نئوپلاسم میلوپرولیفراتیو; myelofibrosis; anaemia; myeloproliferative neoplasm; anaemia treatment
Keywords: نئوپلاسم میلوپرولیفراتیو; myeloproliferative neoplasm; leukemic transformation; leukemia etiology; polycythemia vera; essential thrombocythemia; primary myelofibrosis; antineoplastic agents; alkylators; hydroxyurea; radioactive phosphorous; X-ray treatment; JAK2 mutation; risk fac
Keywords: نئوپلاسم میلوپرولیفراتیو; JAK inhibitor; Myeloproliferative neoplasm; Overall survival; Ruxolitinib; Splenomegaly;
BCR/ABL1-negative, triple-negative, myeloproliferative neoplasm with a hitherto undescribed, isolated, SH2B3 (LNK) gene mutation: A case report
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; SH2B3 (LNK) mutation; JAK2 mutation; CALR mutation; MPL mutation;
Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; ABL1-ETV6 rearrangement; Tyrosine kinase inhibitors;
Myeloid neoplasm with eosinophilia associated with isolated extramedullary FIP1L1/PDGFRA rearrangement
Keywords: نئوپلاسم میلوپرولیفراتیو; Eosinophilia; extramedullary myeloid tumor; FIP1L1-PDGFRA; tyrosine kinase inhibitor; myeloproliferative neoplasm;
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States
Keywords: نئوپلاسم میلوپرولیفراتیو; Activity impairment; Myeloproliferative neoplasm; Quality of life; Symptoms; Work productivity;
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; JAK2 V617F; CALR; MPL; Mutant allele burden;
FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Systemic mastocytosis; Lymphoblastic lymphoma; ZMYM2-FGFR1 translocation; Intron and exon sequencing;
Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms
Keywords: نئوپلاسم میلوپرولیفراتیو; Calreticulin; Somatic mutation; Allele burden; Myeloproliferative neoplasms; Pyrosequencing; BM; bone marrow; ddPCR; digital-droplet PCR; ET; essential thrombocythemia; MPN; myeloproliferative neoplasm; NGS; next-generation sequencing; PB; peripheral bloo
Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis
Keywords: نئوپلاسم میلوپرولیفراتیو; CALR; Portal vein; Myeloproliferative neoplasm; JAK2; Hepatic vein;
Original ArticleThe high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians
Keywords: نئوپلاسم میلوپرولیفراتیو; AML; acute myeloid leukemia; BM; bone marrow; FISH; fluorescence in situ hybridization; MDS; myelodysplastic syndrome; MPN; myeloproliferative neoplasm; NGS; next generation sequencing; RAEB; refractory anemia with excess blasts; RARS; refractory anemia w
JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms
Keywords: نئوپلاسم میلوپرولیفراتیو; JAK-STAT; Myeloproliferative neoplasm; JAK inhibitor; Ruxolitinib; Primary myelofibrosis;
Invited reviewRecommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Myelofibrosis; Diagnosis; Monitoring; Prognosis;
The JAK2V617F mutation in normal individuals takes place in differentiating cells
Keywords: نئوپلاسم میلوپرولیفراتیو; AS-PCR; allele specific PCR; AS-RQ-PCR; allele-specific real-time PCR; ddPCR; digital PCR techniques; ARMS; amplification refractory mutation system;  â Ct; delta threshold cycle; Ct; threshold cycle; EPO; erythropoietin; HSC; hematopoietic stem cell;
The multi-site docking protein Gab1 is constitutively phosphorylated independent from its recruitment to the plasma membrane in Jak2-V617F-positive cells and mediates proliferation of human erythroleukaemia cells
Keywords: نئوپلاسم میلوپرولیفراتیو; AEBSF; 4-(2-aminoethyl)-benzolsulfonylfluorid; DMEM; Dulbecco's modified Eagle's medium; EGFR; epidermal growth factor receptor; Epo; erythropoietin; EpoR; erythropoietin receptor; Erk; extracellular signal regulated kinase; FCS; fetal calf serum; Gab1; G
CALR mutation profile in Irish patients with myeloproliferative neoplasms
Keywords: نئوپلاسم میلوپرولیفراتیو; CALR; Essential thrombocythemia; JAK2; Myeloproliferative neoplasm; Primary myelofibrosis;
Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm
Keywords: نئوپلاسم میلوپرولیفراتیو; All cerebrovascular disease/Stroke; Risk factors in epidemiology; Clinical trials observational study (cohort, case control); JAK2 V617F mutation; Myeloproliferative neoplasm;
BCR–JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia
Keywords: نئوپلاسم میلوپرولیفراتیو; JAK2; BCR–JAK2 fusion; myeloproliferative neoplasm; B-lymphoblastic leukemia/lymphoma; eosinophilia
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
Keywords: نئوپلاسم میلوپرولیفراتیو; Myeloproliferative neoplasm; Myelofibrosis; Therapy; Targeted; Novel; Combination
An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation
Keywords: نئوپلاسم میلوپرولیفراتیو; BM; bone marrow; MPN; myeloproliferative neoplasm; CMD; chronic myeloproliferative disease; DIPSS; dynamic-IPSS; EC; endothelial cells; HSCT; hematopoietic stem cell transplantation; INCA; Instituto Nacional de Câncer; IPSS; International Prognostic Scor
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2V617F or MPL mutations
Keywords: نئوپلاسم میلوپرولیفراتیو; Calreticulin; Mutation; Myeloproliferative neoplasm; Allele burden
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
Keywords: نئوپلاسم میلوپرولیفراتیو; Splanchnic vein thrombosis; Myeloproliferative neoplasm; Bone marrow morphology; Polycythemia vera; Primary myelofibrosis; Essential thrombocythemia
The clinical and laboratory evaluation of the patient with erythrocytosis
Keywords: نئوپلاسم میلوپرولیفراتیو; Erythrocytosis; Polycythemia; Hypoxia; Myeloproliferative neoplasm; JAK2; Erythropoietin
Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis
Keywords: نئوپلاسم میلوپرولیفراتیو; Calreticulin (CALR); Essential thrombocythemia; High-resolution melting analysis; Mutation; Myeloproliferative neoplasm;